Enzo Historical Balance Sheet

ENZ Stock

USD 0.68 0.02 3.03%

Trend analysis of Enzo Biochem balance sheet accounts such as Other Current Liabilities of 27.2 M or Total Current Liabilities of 15.1 M provides information on Enzo Biochem's total assets, liabilities, and equity, which is the actual value of Enzo Biochem to its prevalent stockholders. By breaking down trends over time using Enzo Biochem balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Enzo Biochem latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Enzo Biochem is a good buy for the upcoming year.

Enzo Biochem Inventory

5.61 Million

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.

About Enzo Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Enzo Biochem at a specified time, usually calculated after every quarter, six months, or one year. Enzo Biochem Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Enzo Biochem and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Enzo currently owns. An asset can also be divided into two categories, current and non-current.

Enzo Biochem Balance Sheet Chart

At this time, Enzo Biochem's Other Assets are fairly stable compared to the past year. Good Will is likely to rise to about 8.5 M in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 3 M in 2025.

Short Long Term Debt Total Other Current Liab Total Current Liabilities Cash And Short Term Investments

Add Fundamental

Total Current Liabilities

Total Current Liabilities is an item on Enzo Biochem balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Enzo Biochem are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Enzo Biochem balance sheet. This account contains Enzo Biochem investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Enzo Biochem fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most accounts from Enzo Biochem's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Enzo Biochem current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.At this time, Enzo Biochem's Other Assets are fairly stable compared to the past year. Good Will is likely to rise to about 8.5 M in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 3 M in 2025.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	7.0M	3.5M	3.2M	3.0M
Total Assets	121.9M	85.8M	98.6M	100.6M

Short Long Term Debt Total Total Assets

Enzo Biochem balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Accounts Payable	Short Term Debt	Common Stock Total Equity	Common Stock
Total Assets		0.04	0.26	0.33	0.83	0.49	-0.54	-0.14	0.67	0.24	-0.11	0.81	-0.19	0.45	0.01	0.14	0.26	0.3	0.22	0.42	0.89	-0.57	-0.02	0.09	0.47	0.45
Short Long Term Debt Total	0.04		-0.31	-0.26	-0.45	0.4	0.56	0.65	-0.08	0.43	0.79	-0.01	-0.49	-0.55	0.97	-0.13	-0.11	-0.63	0.86	0.18	-0.16	-0.46	-0.3	0.38	-0.57	-0.57
Other Current Liab	0.26	-0.31		0.5	0.2	0.12	-0.42	-0.31	0.33	-0.09	-0.27	0.33	-0.53	0.35	-0.27	-0.02	0.61	0.26	-0.02	0.48	0.3	0.36	-0.56	-0.13	0.37	0.45
Total Current Liabilities	0.33	-0.26	0.5		0.18	0.51	-0.13	-0.73	0.06	0.27	-0.6	0.09	0.06	0.74	-0.42	0.5	0.23	0.76	0.24	0.44	0.21	0.21	0.12	0.46	0.73	0.73
Total Stockholder Equity	0.83	-0.45	0.2	0.18		0.11	-0.77	-0.31	0.64	-0.05	-0.4	0.72	0.16	0.53	-0.43	0.1	0.16	0.45	-0.34	0.13	0.86	-0.37	0.23	-0.2	0.56	0.53
Property Plant And Equipment Net	0.49	0.4	0.12	0.51	0.11		0.35	-0.36	-0.15	0.83	-0.14	0.01	-0.29	0.43	0.27	0.67	0.47	0.36	0.62	0.8	0.11	-0.28	-0.1	0.61	0.44	0.42
Net Debt	-0.54	0.56	-0.42	-0.13	-0.77	0.35		0.13	-0.86	0.57	0.26	-0.78	-0.02	-0.36	0.49	0.35	-0.07	-0.27	0.45	0.11	-0.8	0.08	0.02	0.5	-0.35	-0.38
Retained Earnings	-0.14	0.65	-0.31	-0.73	-0.31	-0.36	0.13		0.22	-0.26	0.94	0.21	-0.38	-0.83	0.77	-0.66	-0.35	-0.9	0.31	-0.36	-0.02	-0.33	-0.34	-0.28	-0.86	-0.83
Cash	0.67	-0.08	0.33	0.06	0.64	-0.15	-0.86	0.22		-0.47	0.16	0.95	-0.29	0.18	-0.02	-0.47	0.05	0.02	0.0	0.0	0.89	-0.37	-0.24	-0.38	0.15	0.19
Non Current Assets Total	0.24	0.43	-0.09	0.27	-0.05	0.83	0.57	-0.26	-0.47		-0.11	-0.32	-0.08	0.07	0.29	0.63	0.23	0.1	0.5	0.58	-0.22	-0.16	0.11	0.7	0.13	0.06
Non Currrent Assets Other	-0.11	0.79	-0.27	-0.6	-0.4	-0.14	0.26	0.94	0.16	-0.11		0.17	-0.51	-0.77	0.88	-0.5	-0.29	-0.86	0.53	-0.18	-0.06	-0.39	-0.43	-0.17	-0.81	-0.78
Cash And Short Term Investments	0.81	-0.01	0.33	0.09	0.72	0.01	-0.78	0.21	0.95	-0.32	0.17		-0.31	0.22	0.05	-0.37	0.09	0.04	0.09	0.07	0.96	-0.52	-0.22	-0.27	0.19	0.23
Net Receivables	-0.19	-0.49	-0.53	0.06	0.16	-0.29	-0.02	-0.38	-0.29	-0.08	-0.51	-0.31		0.2	-0.59	0.15	-0.57	0.38	-0.51	-0.59	-0.16	0.03	0.92	0.18	0.21	0.12
Common Stock Shares Outstanding	0.45	-0.55	0.35	0.74	0.53	0.43	-0.36	-0.83	0.18	0.07	-0.77	0.22	0.2		-0.63	0.56	0.42	0.96	-0.19	0.42	0.42	0.04	0.18	0.12	0.99	0.99
Non Current Liabilities Total	0.01	0.97	-0.27	-0.42	-0.43	0.27	0.49	0.77	-0.02	0.29	0.88	0.05	-0.59	-0.63		-0.25	-0.04	-0.75	0.77	0.15	-0.12	-0.46	-0.45	0.18	-0.66	-0.63
Inventory	0.14	-0.13	-0.02	0.5	0.1	0.67	0.35	-0.66	-0.47	0.63	-0.5	-0.37	0.15	0.56	-0.25		0.27	0.62	0.1	0.57	-0.15	0.18	0.24	0.28	0.57	0.51
Other Current Assets	0.26	-0.11	0.61	0.23	0.16	0.47	-0.07	-0.35	0.05	0.23	-0.29	0.09	-0.57	0.42	-0.04	0.27		0.27	0.01	0.82	0.15	0.17	-0.64	-0.11	0.46	0.53
Other Stockholder Equity	0.3	-0.63	0.26	0.76	0.45	0.36	-0.27	-0.9	0.02	0.1	-0.86	0.04	0.38	0.96	-0.75	0.62	0.27		-0.27	0.29	0.26	0.17	0.37	0.19	0.95	0.93
Total Liab	0.22	0.86	-0.02	0.24	-0.34	0.62	0.45	0.31	0.0	0.5	0.53	0.09	-0.51	-0.19	0.77	0.1	0.01	-0.27		0.41	-0.01	-0.36	-0.31	0.54	-0.22	-0.22
Property Plant And Equipment Gross	0.42	0.18	0.48	0.44	0.13	0.8	0.11	-0.36	0.0	0.58	-0.18	0.07	-0.59	0.42	0.15	0.57	0.82	0.29	0.41		0.16	0.06	-0.52	0.15	0.45	0.48
Total Current Assets	0.89	-0.16	0.3	0.21	0.86	0.11	-0.8	-0.02	0.89	-0.22	-0.06	0.96	-0.16	0.42	-0.12	-0.15	0.15	0.26	-0.01	0.16		-0.5	-0.07	-0.23	0.41	0.42
Intangible Assets	-0.57	-0.46	0.36	0.21	-0.37	-0.28	0.08	-0.33	-0.37	-0.16	-0.39	-0.52	0.03	0.04	-0.46	0.18	0.17	0.17	-0.36	0.06	-0.5		-0.14	-0.2	0.04	0.08
Accounts Payable	-0.02	-0.3	-0.56	0.12	0.23	-0.1	0.02	-0.34	-0.24	0.11	-0.43	-0.22	0.92	0.18	-0.45	0.24	-0.64	0.37	-0.31	-0.52	-0.07	-0.14		0.36	0.19	0.07
Short Term Debt	0.09	0.38	-0.13	0.46	-0.2	0.61	0.5	-0.28	-0.38	0.7	-0.17	-0.27	0.18	0.12	0.18	0.28	-0.11	0.19	0.54	0.15	-0.23	-0.2	0.36		0.14	0.09
Common Stock Total Equity	0.47	-0.57	0.37	0.73	0.56	0.44	-0.35	-0.86	0.15	0.13	-0.81	0.19	0.21	0.99	-0.66	0.57	0.46	0.95	-0.22	0.45	0.41	0.04	0.19	0.14		0.99
Common Stock	0.45	-0.57	0.45	0.73	0.53	0.42	-0.38	-0.83	0.19	0.06	-0.78	0.23	0.12	0.99	-0.63	0.51	0.53	0.93	-0.22	0.48	0.42	0.08	0.07	0.09	0.99

Click cells to compare fundamentals

Enzo Biochem Account Relationship Matchups

Enzo Biochem balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	113.7M	95.9M	121.9M	85.8M	98.6M	100.6M
Short Long Term Debt Total	22.7M	20.6M	7.0M	3.5M	3.2M	3.0M
Other Current Liab	8.1M	8.2M	34.5M	22.5M	25.9M	27.2M
Total Current Liabilities	26.1M	24.6M	40.0M	24.8M	28.5M	15.1M
Total Stockholder Equity	68.6M	54.5M	78.5M	56.1M	64.5M	74.8M
Property Plant And Equipment Net	33.6M	32.4M	16.7M	15.2M	17.5M	12.5M
Net Debt	9.2M	(1.0M)	(75.4M)	(48.9M)	(44.0M)	(46.2M)
Retained Earnings	(270.4M)	(288.6M)	(268.4M)	(294.4M)	(265.0M)	(251.7M)
Cash	13.5M	21.6M	82.4M	52.4M	60.2M	42.5M
Non Current Assets Total	43.1M	41.5M	23.4M	15.7M	18.1M	32.0M
Non Currrent Assets Other	1.8M	1.6M	1.7M	530K	477K	453.2K
Cash And Short Term Investments	43.5M	21.6M	82.4M	52.4M	60.2M	46.6M
Net Receivables	10.2M	4.8M	4.8M	4.0M	4.6M	4.4M
Common Stock Shares Outstanding	48.3M	48.6M	49.2M	50.9M	58.5M	37.4M
Liabilities And Stockholders Equity	113.7M	95.9M	121.9M	85.8M	98.6M	100.6M
Non Current Liabilities Total	19.0M	16.8M	3.4M	4.9M	4.4M	7.8M
Inventory	12.7M	15.4M	7.9M	6.8M	7.9M	5.6M
Other Current Assets	4.2M	6.9M	3.3M	6.8M	7.9M	8.3M
Other Stockholder Equity	337.1M	339.5M	344.4M	348.1M	400.4M	220.0M
Total Liab	45.1M	41.4M	43.4M	29.7M	26.7M	18.8M
Property Plant And Equipment Gross	33.6M	63.9M	34.0M	32.0M	36.8M	38.6M
Total Current Assets	70.6M	54.4M	98.5M	70.0M	80.5M	68.6M
Accumulated Other Comprehensive Income	1.4M	3.2M	1.9M	1.9M	2.2M	2.3M
Intangible Assets	1.0M	538K	244K	7.5M	6.7M	6.7M
Accounts Payable	8.1M	3.7M	3.6M	1.4M	1.6M	1.5M
Short Term Debt	7.2M	1.1M	2.0M	917K	825.3K	784.0K
Common Stock Total Equity	476K	479K	485K	487K	560.1K	422.6K
Common Stock	485K	487K	499K	521K	599.2K	433.3K
Other Assets	1.4M	1.8M	1.6M	6.7M	6.0M	6.3M
Property Plant Equipment	14.5M	33.6M	17.3M	16.7M	19.2M	10.2M
Current Deferred Revenue	2.5M	2.7M	11.7M	5.9M	6.8M	3.7M
Long Term Debt	4.4M	4.1M	269K	189K	217.4K	206.5K
Net Tangible Assets	50.4M	60.9M	47.0M	78.5M	90.2M	58.6M
Capital Surpluse	334.5M	337.1M	339.5M	344.4M	396.1M	359.7M
Non Current Liabilities Other	424K	16.9M	5K	12.8M	14.7M	15.4M
Short Long Term Debt	152K	229K	2.6M	76K	68.4K	65.0K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
V	Visa Class A
C	Citigroup

Additional Tools for Enzo Stock Analysis

When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Enzo Historical Balance Sheet

Enzo Biochem Inventory

5.61 Million

About Enzo Balance Sheet Analysis

Enzo Biochem Balance Sheet Chart

Total Current Liabilities

Cash And Short Term Investments

Enzo Biochem balance sheet Correlations

Enzo Biochem Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Enzo Biochem balance sheet Accounts

Also Currently Popular

Additional Tools for Enzo Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock Total Equity	+ 0.99	Common Stock Shares Outstanding
Common Stock	+ 0.99	Common Stock Shares Outstanding
Common Stock	+ 0.99	Common Stock Total Equity
Non Current Liabilities Total	+ 0.97	Short Long Term Debt Total
Total Current Assets	+ 0.96	Cash And Short Term Investments
Other Stockholder Equity	+ 0.96	Common Stock Shares Outstanding

Other Stockholder Equity	- 0.9	Retained Earnings
Other Stockholder Equity	- 0.86	Non Currrent Assets Other
Common Stock Total Equity	- 0.86	Retained Earnings
Cash	- 0.86	Net Debt
Common Stock	- 0.83	Retained Earnings
Common Stock Shares Outstanding	- 0.83	Retained Earnings